Everest Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference
Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that Ian Woo, President and Chief Financial Officer, will present a company update and that the management team including chairman Bill Wu and Chief Executive Officer Rogers Luo will participate […]